Abstract
For products derived from continuous cell lines, regulatory agencies worldwide require that the purification process be validated for its ability to remove or inactivate potential contaminants such as viruses and virus-like particles. New guidance suggests a requirement for statistical evaluation of these studies but the industry has yet to develop such standards. The task of estimating excess capacity is also complicated by variable assays, accumulation of variability in clearance estimates over unit operations, dependence of clearance capacity on operating parameters, and expense of experiments. We propose an experimental strategy to determine the excess clearance capacity of a biopharmaceutical process and to provide statistical estimation of excess capacity in an efficient way. Clearance estimates and their variances are calculated for each orthogonal unit operation and estimates are combined to form an interval estimate of overall process clearance capacity. Poisson regression is suggested as an efficient technique for data analysis of clearance studies. We believe that this approach should meet regulatory guidelines in a cost effective way, while clarifying the roles of qualitative and quantitative components in setting requirements.
Similar content being viewed by others
References
Lubiniecki AS, Wiebe ME, and Builder SE (1990) Process validation for cell culture derived pharmaceutical proteins. In Lubiniecki AS (ed.) Large Scale Mammalian Cell Culture Technology, Marcel Dekker Inc, NY, pp. 515–541.
Office of Biologics Research and Review (1993) “Points to consider in the manufacture and testing of monoclonal antibody products for human use”, Food and Drug Administration, Md, 1994 and Office of Biologics Research and Review, “Points to consider in the characterization of cell lines used to produce biologicals”, Food and Drug Administration, Md.
Commission of the European Communities, (1991) Note for Guidance: Validation of virus removal and inactivation procedures. Brussels. Belgium.
Dinowitz M, Lie YS, Low M-AL, Lazar R, Fautz C, Potts B, Sernatinger J, and Anderson K, (1992) Recent studies on retrovirus-like particles in Chinese hamster ovary cells. Develop. Biol. Standard. 76: 201–207.
Lubiniecki AS, Dinowitz M, Nelson E, Wiebe M, May L, Ogez J and Builder S (1989) Endogenous retroviruses of continuous cell substrates. Develop. Biol. Standard., 70: 187–191.
Levine HL, Tarnowski SJ, Dosmar M, Fenton DM, Gabler R, Gardner JN, Hageman TC, Lu P, Sofer G and Steininger R. (1991) Industry perspective on the validation of columnbased separation processes for the purification of proteins. J. Parenteral Science & Technol. 46: 87–97.
Assaad F and Cockburn WC (1982) The relation between acute persisting spinal paralysis and poliomyelitis vaccine — result of a ten year enquiry. Bu'l WHO 60: 231–242.
Center for Disease (1977) Control and Morbidity and Mortality Weekly Report. Sept. 23, 26: 309.
Champagne S, Thomas E and Furesz J. (1987) A case of mumps meningitis: a post immunization complication. Can. Dis. Weekly Rep. 13: 155–157.
Miller E, Goldacre M, Pugh S, Colville A, Farrington P, Flower A, Nash J, MacFarlane L and Tettmar R (1993) Risk of aseptic meningitis after measles, mumps, and rubella vaccine in UK children. Lancet 341: 979–983.
Fradkin JE, Schonberger LB, Mills JI, Gunn WJ, Piper JM, Wysowski DK, Thomson R, Durako S and Brown P (1991) Creutzfeld-Jakob disease in pituitary growth hormone recipients in the United States. JAMA, 265: 880–884.
Frome EL, Kutner MH and Beauchamp JJ (1973) Regression analysis of poisson-distributed data. Journal of the American Statistical Association, 68, 935–940.
Roussel PH and Husson J (1991) Estimating viral concentrations from dilution counts: a reliable computation method programmed on a pocket calculator, Journal of Virological Methods 34, 113–140.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Shadle, P.J., McAllister, P.R., Smith, T.M. et al. Viral validation strategy for recombinant products derived from established animal cell lines. Cytotechnology 18, 21–25 (1995). https://doi.org/10.1007/BF00744316
Issue Date:
DOI: https://doi.org/10.1007/BF00744316